Melhores Linfoma de Burkitt médicos em Israel - TOP-20 médicos

O Dr. Ram Ron trata o linfoma de Burkitt no Centro Médico Sourasky (Ichilov), um dos maiores e mais avançados hospitais de Israel.

• Mais de 25 anos de experiência em oncologia clínica
• Possuir uma bolsa de um centro internacional líder em medicina reprodutiva
• Tratar com uma gama de procedimentos, incluindo a inseminação intrauterina
• Formado pela Universidade de Mysore, na Índia

Realizou várias centenas de transplantes de células estaminais – um tratamento fundamental para linfomas agressivos. O Dr. Ram é um hematologista-oncologista com tripla certificação, baseado no Hospital Ichilov.

• Mais de 30 artigos publicados e um capítulo de livro sobre cancros do sangue
• Formação especializada (Fellowship) no New York Medical College em hematologia e oncologia
• Possui certificações em medicina interna, hematologia e oncologia médica

Chefe de Onco-hematologia Pediátrica do Dana Dwek Children’s Hospital – a Dra. El Hasid é especialista em transplantes de medula óssea e sangue de cordão umbilical em crianças.

• Realizar mais de 300 procedimentos de transplante
• Publicar mais de 50 artigos de pesquisa em oncologia pediátrica
• Ser membro da American Association for Hematology
• Formar-se no City of Hope Hospital em Los Angeles

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

O Dr. Michael Shapira é especialista em Transplante de Medula Óssea no Sourasky Medical Center (Ichilov), com vasta experiência no tratamento de cancros do sangue.

• Licenciar-se pela Faculdade de Medicina da Universidade Hebraica
• Especializar-se em medicina interna no Hadassah Medical Center
• Médico sénior em Transplante de Medula Óssea na Hadassah

O Dr. Fredi Aviv tem mais de 30 anos de experiência no tratamento de cancros do sangue no principal Centro Médico Sourasky de Tel Aviv.

• 31 anos dedicados à onco-hematologia
• Especialização em cancros do sangue agressivos
• Prática no renomado Centro Médico Sourasky
• Experiência nas mais recentes terapias médicas e biológicas

O Dr. Dror Levin é especializado em hematologia-oncologia pediátrica, com foco no linfoma de Burkitt no Sourasky Medical Center em Tel Aviv.

• Diretor do departamento de hematologia-oncologia infantil no Sourasky Medical Center
• Especializado em hematologia e oncologia pediátrica no Schneider Children's Medical Center
• Membro da Sociedade de Hematologia e Oncologia Pediátrica de Israel (ISPHO)
• Estudar oncologia de ossos e tecidos moles no Rizzoli Orthopaedic Institute, na Itália

Um proeminente especialista em hematologia reconhecido pela American Society of Hematology, o Dr. Yair trata pacientes no Sourasky Medical Center de Tel Aviv.

• Realizar residência especializada em hematologia no Centro Médico de Tel Aviv
• Ser vencedor de múltiplas bolsas de pesquisa e prêmios de excelência clínica
• Ser membro ativo das associações de hematologia israelense e americana
• Focar na pesquisa de leucemia, incluindo formas linfocíticas

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Especialista em onco-hematologia, tratando cancros do sangue e do sistema linfático no Assuta Medical Center.

• Concentrar-se exclusivamente em neoplasias hematológicas, como o linfoma de Burkitt
• Fornecer diagnóstico especializado e planeamento de tratamento para cancros do sangue complexos
• Trabalhar na prestigiada rede de hospitais Assuta em Israel

Mais de 3.500 transplantes de medula óssea realizados – o Dr. Stepensky é reconhecido pela Forbes como um dos melhores médicos.

• 20 anos de prática especializada em hematologia pediátrica
• Especialista no tratamento de crianças com cancros do sangue raros, como o linfoma de Burkitt
• Atua no Hadassah Medical Center, em Israel
• Conhecido pelo elevado nível de competência e cuidados compassivos

A Professora Zila Zuckerman é especialista em Hematologia e Transplantologia, com foco em cancros do sangue no Rambam Medical Center.

• Subespecialista em transplantologia para distúrbios sanguíneos
• Professora académica com expertise em investigação
• Trabalha num centro médico nacional de referência

Especialista no tratamento de linfomas no Rambam Medical Center.

• Concentrar-se em hematologia com vasta experiência em casos de linfoma
• Trabalhar num centro médico líder, conhecido pelos cuidados oncológicos
• Dedicar-se a fornecer planos de tratamento personalizados para os pacientes

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.